S'abonner

Prematurity Does Not Increase Early Childhood Fracture Risk - 09/12/18

Doi : 10.1016/j.jpeds.2018.11.017 
Kari Wagner, MD 1, 2, Scott Wagner, MD 3, 4, Apryl Susi, MS 2, Gregory Gorman, MD, MHS 1, 2, Elizabeth Hisle-Gorman, MSW, PhD 2
1 Department of Pediatrics, Walter Reed National Military Medical Center, Bethesda, MD 
2 Department of Pediatrics, Uniformed Services University, Bethesda, MD 
3 Department of Orthopedic Surgery, Walter Reed National Military Medical Center, Bethesda, MD 
4 Department of Orthopedic Surgery, Uniformed Services University, Bethesda, MD 

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Sunday 09 December 2018

Abstract

Objective

To evaluate the impact of prematurity on fracture by age 5, controlling for medications and comorbidities of prematurity.

Study design

We performed a retrospective cohort study of infants born in Military Treatment Facilities in 2009-2010 with ≥5 years of follow-up care. Gestational age, low birth weight, comorbidities of prematurity (osteopenia, necrotizing enterocolitis, chronic lung disease, and cholestasis) and fractures were identified by International Classification of Disease, 9th Edition, codes. Pharmaceutical records identified treatment with caffeine, diuretics, postnatal corticosteroids, and antacids. Poisson regression analysis determined fracture rate by 5 years of life.

Results

There were 65 938 infants born in 2009-2010 who received care in the military health system for ≥5 years, including 3589 born preterm; 165 born at ≤286/7 weeks of gestation, 380 born at 29-316/7 weeks of gestation, and 3044 born at 32-366/7 weeks of gestation. Preterm birth at any gestational age was not associated with fracture rate in adjusted models. The fracture rate was increased with cholestasis, proton pump inhibitor exposure, and male sex.

Conclusions

Prematurity was not associated with fracture rate. Neonatal cholestasis and proton pump inhibitor treatment were associated with increased fractures by age 5.

Le texte complet de cet article est disponible en PDF.

Keywords : fracture, preterm birth, cholestasis, proton pump inhibitors, metabolic bone disease, diuretics, postnatal corticosteroids

Abbreviations : ICD-9-CM, LBW, NEC, PPI


Plan


 The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government. Some authors are a military service member or a U.S. Government employee. This work was prepared as part of their official duties. Title 17 U.S.C. 105 provides that “Copyright protection under this title is not available for any work of the United States Government.” Title 17 U.S.C. 101 defines a United States Government work as a work prepared by a military service member or employee of the United States Government as part of that person's official duties. The authors declare no conflicts of interest.
 Portions of this study were presented at the Uniformed Services Pediatric Seminar, October 23, 2016, San Francisco, CA; the Pediatric Academic Society annual meeting, May 3, 2016, Baltimore, MD; Eastern Society for Pediatric Research Annual Meeting, March 13, 2016, Philadelphia, PA; and the Academic Pediatric Association Region IV Annual Meeting, February 20, 2016, Charlottesville, VA.


© 2018  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.